India–Norway Backed Elmentoz Research Secures Seed Round to Revolutionize the future of animal nutrition and Smart Feed Technology
Elmentoz Research Pvt. Ltd., a deep-tech biotechnology company pioneering precision animal health nutrition and smart feed solutions for poultry, aquaculture, and pet food, has announced the closure of its first seed funding round from angel investors in India and Norway. With this investment, Elmentoz is establishing India’s largest BSF-based smart protein facility, capable of processing 2,000 MT per month of industrial byproducts through its proprietary advanced automation technologies.
The facility is scheduled to open to the market in January 2026, marking a major milestone for India’s sustainable feed and next-generation smart protein industry.
This capital infusion will accelerate Elmentoz’s mission to build sustainable, next-generation biofeed solutions that address India’s heavy import reliance on functional feed additives, reduce biosecurity vulnerabilities—including the rising challenge of antimicrobial resistance—and improve farmers’ profitability.
It strengthens our India-first, research-driven insect protein platform, delivering measurable reductions in land use, water consumption, and carbon footprints.
Elmentoz’s IP-led innovation platform integrates genomics, proteomics, advanced automation, and cGMP manufacturing to deliver AMP-fortified immune-smart premixes, smart protein formulations, and functional oil ingredients under its flagship product lines—ELGROW and ELTIDE. The company’s precision-nutrition approach enhances gut health, improves feed conversion, and strengthens disease resilience, replacing antibiotic growth promoters (AGPs) with functional immuno-nutrition solutions.
Seed proceeds will be used to:
• Scale India’s first advanced automated cGMP smart-protein manufacturing facility
• Expand ELGROW and ELTIDE product portfolios
• Advance antimicrobial peptide (AMP) technology and platform development
• Strengthen strategic international partnerships
• Grow research, manufacturing, and commercial teams to support rapid expansion
Commenting on the capital infusion, Dr. Jayashankar Das, Founder and CEO, Elmentoz Research Pvt. Ltd., said: “India, as an agrarian economy, must prioritise nutritional security, not just food security. Our research driven insect protein and antimicrobial peptide platforms deliver consistent amino acid profiles, better gut health, and antibiotic free performance across poultry, aquaculture, and pet segments. With rigorous genomics, proteomics, and advanced cGMP manufacturing, we can replace AGPs with targeted functional feeds that are safer, smarter, and more resilient for farmers and feed manufacturers.”
Dr. Padmaja Mohanty, Co Founder & CTO, Elmentoz Research Pvt. Ltd., added: “Insects are nature’s most efficient bio converters and at Elmentoz, they become drivers of sustainable protein security. This funding enables us to deepen and scale our research to better understand the mechanisms driving animal health and performance and translate those insights into precision feed formulations. After all, sustainability isn’t a feature, it is the operating system for the next decade of animal nutrition.”
Christen Hveem, an angel investor from Norway “Nutritional security is fast becoming one of the world’s most urgent priorities. India, with innovators like Elmentoz, has the capability to become a global powerhouse in next-generation smart proteins and precision nutrition for the feed industry. What Elmentoz is building is not just a company—it is a transformative platform that can shape the future of sustainable food systems.”
Elmentoz is creating India’s first robust, research driven insect protein line, an untapped opportunity poised to shape the global insect enabled feed industry.
About Elmentoz Research Pvt. Ltd.
Elmentoz Research Pvt. Ltd. is a deep tech biotech company at the forefront of precision animal health nutrition and smart feed manufacturing for poultry, aquaculture, and pet food industries. Founded in December 2022 by Dr. Jayashankar Das and Dr. Padmaja Mohanty, Elmentoz integrates genomics, proteomics, advance automation and cGMP manufacturing to produce alternative protein formulations and functional antimicrobial peptides (AMPs). The company’s product portfolio includes ELGROW (precision smart protein formulation lines) and ELTIDE (Immune smart premix), designed to improve feed conversion, gut health, and disease resilience while reducing reliance on antibiotic growth promoters (AGPs). Elmentoz operates India’s first cGMP smart protein manufacturing facility with state of the art insect, fats & oils, and peptide research labs, supported by strategic automation partnerships. The company’s IP portfolio includes granted and filed patents and trademarks, and a multidisciplinary team advancing sustainable, cost effective solutions for core animal health segments. Locations: Hyderabad and Bhubaneswar, India.
